Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 15;192(24):E651.
doi: 10.1503/cmaj.191231.

Immune checkpoint inhibitors in cancer immunotherapy

Megan E Himmel  1 , Samuel D Saibil  1 , Alexandra P Saltman  2
Affiliations

Immune checkpoint inhibitors in cancer immunotherapy

Megan E Himmel et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Samuel Saibil has received personal fees from Janssen and Novartis outside the submitted work. No other competing interests were declared.

References

    1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12: 252–64. - PMC - PubMed
    1. Nixon NA, Blais N, Ernst S, et al. Current landscape of immune therapy in treatment of solid tumours, with future opportunities and challenges. Curr Oncol 2018; 25: E373–84. - PMC - PubMed
    1. Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2019;381:1535–46. - PubMed
    1. SEER stat fact sheets: melanoma of the skin. Bethesda (MD): National Cancer Institute, Surveillance Epidemiology and End Results (SEER) Program; 2016. Available: https://seer.cancer.gov/statfacts/html/melan.html (accessed 2020 May 31).
    1. Immune checkpoint inhibitor toxicity: clinical practice guideline. Toronto: Cancer Care Ontario; 2018. Available: www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/52976 (accessed 2020 May 31).

MeSH terms

Substances